Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth
- PMID: 11297520
- DOI: 10.1074/jbc.M009953200
Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth
Abstract
Peutz-Jeghers syndrome is an inherited cancer syndrome that results in a greatly increased risk of developing tumors in those affected. The causative gene is a protein kinase termed LKB1, predicted to function as a tumor suppressor. The mechanism by which LKB1 is regulated in cells is not known. Here, we demonstrate that stimulation of Rat-2 or embryonic stem cells with activators of ERK1/2 or of cAMP-dependent protein kinase induced phosphorylation of endogenously expressed LKB1 at Ser(431). We present pharmacological and genetic evidence that p90(RSK) mediated this phosphorylation in response to agonists that activate ERK1/2 and that cAMP-dependent protein kinase mediated this phosphorylation in response to agonists that activate adenylate cyclase. Ser(431) of LKB1 lies adjacent to a putative prenylation motif, and we demonstrate that full-length LKB1 expressed in 293 cells was prenylated by addition of a farnesyl group to Cys(433). Our data suggest that phosphorylation of LKB1 at Ser(431) does not affect farnesylation and that farnesylation does not affect phosphorylation at Ser(431). Phosphorylation of LKB1 at Ser(431) did not alter the activity of LKB1 to phosphorylate itself or the tumor suppressor protein p53 or alter the amount of LKB1 associated with cell membranes. The reintroduction of wild-type LKB1 into a cancer cell line that lacks LKB1 suppressed growth, but mutants of LKB1 in which Ser(431) was mutated to Ala to prevent phosphorylation of LKB1 were ineffective in inhibiting growth. In contrast, a mutant of LKB1 that cannot be prenylated was still able to suppress the growth of cells.
Similar articles
-
LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):673-80. Biochem J. 2000. PMID: 10642527 Free PMC article.
-
Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome.Biochem J. 2002 Mar 1;362(Pt 2):481-90. doi: 10.1042/0264-6021:3620481. Biochem J. 2002. PMID: 11853558 Free PMC article.
-
Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.Hum Mutat. 2003 Feb;21(2):172. doi: 10.1002/humu.9112. Hum Mutat. 2003. PMID: 12552571
-
LKB1, a protein kinase regulating cell proliferation and polarity.FEBS Lett. 2003 Jul 3;546(1):159-65. doi: 10.1016/s0014-5793(03)00642-2. FEBS Lett. 2003. PMID: 12829253 Review.
-
Genetic screening for Peutz-Jeghers syndrome.Expert Rev Mol Diagn. 2003 Jul;3(4):471-9. doi: 10.1586/14737159.3.4.471. Expert Rev Mol Diagn. 2003. PMID: 12877386 Review.
Cited by
-
Initiating and growing an axon.Cold Spring Harb Perspect Biol. 2010 Apr;2(4):a001925. doi: 10.1101/cshperspect.a001925. Cold Spring Harb Perspect Biol. 2010. PMID: 20452947 Free PMC article. Review.
-
TLR4 counteracts BVRA signaling in human leukocytes via differential regulation of AMPK, mTORC1 and mTORC2.Sci Rep. 2019 May 7;9(1):7020. doi: 10.1038/s41598-019-43347-8. Sci Rep. 2019. PMID: 31065010 Free PMC article.
-
Dendritic cell-intrinsic LKB1-AMPK/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity.JCI Insight. 2023 Jun 8;8(11):e157948. doi: 10.1172/jci.insight.157948. JCI Insight. 2023. PMID: 37140993 Free PMC article.
-
The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.Endocrinology. 2015 Mar;156(3):1156-70. doi: 10.1210/en.2014-1619. Epub 2015 Jan 5. Endocrinology. 2015. PMID: 25560828 Free PMC article.
-
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.Biochem J. 2007 Jan 1;401(1):29-38. doi: 10.1042/BJ20061088. Biochem J. 2007. PMID: 17040210 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous